Insider Cluster (1 insider) ·Filed Mar 17, 2026

CORT

CORCEPT THERAPEUTICS INC
NEUTRAL
Impact 4/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $2.9M total
Actionable Insight • Neutral

Monitor for additional insider selling; this single sale is routine and not indicative of distress, but track whether it's part of a broader trend ahead of earnings or regulatory events.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
CORT ▲ +131.24% at T+60d
NEUTRAL call ✓ call won +131.24% · α vs SPY +121.38% · entry $33.51 → $77.49
Entry anchored
Mar 16, 03:59 PM ET
via exchange tick
T+1d
-0.63%
call -0.63% · α +0.77%
$33.30
settled 7mo ago
T+5d
+0.93%
call +0.93% · α +3.58%
$33.82
settled 6mo ago
T+20d
+31.01%
call +31.01% · α +26.71%
$43.90
settled 6mo ago
T+60d
+131.24%
call +131.24% · α +121.38%
$77.49
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Chief Development Officer William Guyer exercised stock options and sold 11,767 shares in the open market for approximately $424,000. The transaction was part of a pre-arranged plan or routine post-exercise sale, with no open-market purchases observed in the cluster.

Key Financial Metrics

Direction
selling
Total Value
$423.7K
Insiders
1

Key Facts

  • William Guyer, Chief Development Officer, exercised 23,534 derivative securities on March 20, 2026, in two tranches: one non-cash exercise (11,767 shares at $0) and one at $21.65 per share.
  • He sold 11,767 shares in the open market at $36.01, generating $423,730 in proceeds.
  • Total value of open-market sale represents ~0.012% of company's $3.6B market cap — well below materiality threshold.

Financial Impact

$423,730 in open-market share sales by C-suite executive

insider ownershippotential dilution

Risk Factors

  • Perception risk if viewed as insider exiting position, though likely routine option exercise and sale
  • Potential for misinterpretation due to lack of public 10b5-1 plan disclosure timing

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (3 trades, 7d window)cluster-CORT-1774385713966
26 reports for CORT
Performance horizon
100% Hit rate 7 of 7 directional calls best @ T+60▲ +63.06%Feb 24, 2026
Filters
Rows
Reports for CORT — sortable, filterable
TypeNow
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$113.88 $115.63▲ +1.54%▲ +1.28%$116.49 (+2.29%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$113.88 $116.10▲ +1.95%▲ +1.44%$116.49 (+2.29%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$116.93 $117.00▲ +0.06%▲ +0.16%$116.49 (−0.38%)
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$121.05 $114.86▼ −5.11%▼ −5.11%$116.49 (−3.77%)
Aug 18, 2026
6w ago
Insider Cluster
BEARISH ★ 4/10
$118.10 $111.85▲ +5.29%▲ +4.30%$116.49 (+1.36%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$112.18 $114.92▲ +2.44%▲ +4.34%$116.49 (+3.84%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$112.18 $114.92▲ +2.44%▲ +4.34%$116.49 (+3.84%)
Aug 6, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$110.77 $111.62▲ +0.77%▲ +1.16%$116.49 (+5.16%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$107.95 $112.80▲ +4.49%▲ +3.89%$116.49 (+7.91%)
Jul 23, 2026
10w ago
Court Ruling
BULLISH ★ 4/10
$96.66 $121.05▲ +25.23%▲ +21.92%$116.49 (+20.52%)
Showing 10 of 26

US Market Status

Market Open — Closes in 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 24, 2026